Additional file 1: of Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial

Vogelmeier, Claus; Gaga, Mina; Aalamian-Mattheis, Maryam; Greulich, Timm; Marin, Jose; Castellani, Walter; Ninane, Vincent; Lane, Stephen; Nunez, Xavier; Patalano, Francesco; Clemens, Andreas; Kostikas, Konstantinos

doi:10.6084/m9.figshare.c.3830008_D1.v1

12931_2017_622_MOESM1_ESM.docx (980.97 kB)

Additional file 1: of Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial

journal contribution

posted on 2017-07-18, 05:00 authored by Claus Vogelmeier, Mina Gaga, Maryam Aalamian-Mattheis, Timm Greulich, Jose Marin, Walter Castellani, Vincent Ninane, Stephen Lane, Xavier Nunez, Francesco Patalano, Andreas Clemens, Konstantinos Kostikas

Supplementary file for the CRYSTAL study. (DOCX 984Â kb)

Funding

Novartis

History

Usage metrics

Keywords

Chronic obstructive pulmonary disease Dual bronchodilation Indacaterol/glycopyrronium Direct switch Open-label

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial

Funding

Novartis

History

Usage metrics

Categories

Keywords

Licence

Exports